Acute lipopolysaccharide priming boosts inflammasome activation independently of inflammasome sensor induction

Immunobiology

Volumn 217, Issue 12, 2012, Pages 1325-1329

  Schroder, Kate ^a   Sagulenko, Vitaliya ^a   Zamoshnikova, Alina ^a   Richards, Ayanthi A ^a   Cridland, Jasmyn A ^a   Irvine, Katharine M ^a   Stacey, Katryn J ^a   Sweet, Matthew J ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Caspase 1; Inflammasome; Lipopolysaccharide; Priming

Indexed keywords

ABSENT IN MELANOMA 2; ADENOSINE TRIPHOSPHATE; CRYOPYRIN; DNA; INFLAMMASOME; INTERLEUKIN 18; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; LIPOPOLYSACCHARIDE; NIGERICIN; UNCLASSIFIED DRUG;

ARTICLE; ENZYME ACTIVATION; HUMAN; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN INDUCTION; UPREGULATION;

ANIMALS; CARRIER PROTEINS; CASPASE 1; CELLS, CULTURED; CYTOKINES; DNA; HUMANS; INFLAMMASOMES; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; NUCLEAR PROTEINS; PROMOTER REGIONS, GENETIC; RNA, MESSENGER; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 84869088114     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2012.07.020     Document Type: Article

References (11)

1. Bauernfeind F., Bartok E., Rieger A., Franchi L., Nunez G., Hornung V. Cutting edge: reactive oxygen species inhibitors block priming, but not activation, of the NLRP3 inflammasome. J. Immunol. 2011, 187:613-617.
2. Bauernfeind F.G., Horvath G., Stutz A., Alnemri E.S., MacDonald K., Speert D., Fernandes-Alnemri T., Wu J., Monks B.G., Fitzgerald K.A., Hornung V., Latz E. Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J. Immunol. 2009, 183:787-791.
3. Gross O., Yazdi A.S., Thomas C.J., Masin M., Heinz L.X., Guarda G., Quadroni M., Drexler S.K., Tschopp J. Inflammasome activators induce interleukin-1alpha secretion via distinct pathways with differential requirement for the protease function of caspase-1. Immunity 2012, 36:388-400.
4. Guarda G., Braun M., Staehli F., Tardivel A., Mattmann C., Forster I., Farlik M., Decker T., Du Pasquier R.A., Romero P., Tschopp J. Type I interferon inhibits interleukin-1 production and inflammasome activation. Immunity 2011, 34:213-223.
5. Liao Z., Grimshaw R.S., Rosenstreich D.L. Identification of a specific interleukin 1 inhibitor in the urine of febrile patients. J. Exp. Med. 1984, 159:126-136.
6. Roberts T.L., Idris A., Dunn J.A., Kelly G.M., Burnton C.M., Hodgson S., Hardy L.L., Garceau V., Sweet M.J., Ross I.L., Hume D.A., Stacey K.J. HIN-200 proteins regulate caspase activation in response to foreign cytoplasmic DNA. Science 2009, 323:1057-1060.
7. Schroder K., Irvine K.M., Taylor M.S., Bokil N.J., Le Cao K.A., Masterman K.A., Labzin L.I., Semple C.A., Kapetanovic R., Fairbairn L., Akalin A., Faulkner G.J., Baillie J.K., Gongora M., Daub C.O., Kawaji H., McLachlan G.J., Goldman N., Grimmond S.M., Carninci P., Suzuki H., Hayashizaki Y., Lenhard B., Hume D.A., Sweet M.J. Conservation and divergence in Toll-like receptor 4-regulated gene expression in primary human versus mouse macrophages. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:E944-E953.
8. Schroder K., Tschopp J. The inflammasomes. Cell 2010, 140:821-832.
9. Shenoy A.R., Wellington D.A., Kumar P., Kassa H., Booth C.J., Cresswell P., Macmicking J.D. GBP5 promotes NLRP3 inflammasome assembly and immunity in mammals. Science 2012, 336:481-485.
10. Shi C.S., Shenderov K., Huang N.N., Kabat J., Abu-Asab M., Fitzgerald K.A., Sher A., Kehrl J.H. Activation of autophagy by inflammatory signals limits IL-1beta production by targeting ubiquitinated inflammasomes for destruction. Nat. Immunol. 2012, 13:255-263.
11. Tschopp J., Schroder K. NLRP3 inflammasome activation: the convergence of multiple signalling pathways on ROS production?. Nat. Rev. Immunol. 2010, 10:210-215.